Journal Article

DZNE-2025-01194

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Comparing loss of individual fragile X proteins suggests strong links to cellular senescence and aging.

Menge, S. ; Segura, I. ; Hartmann, M. ; Decker, L. ; Kiran, S.Extern* ; Danzer, K. M.DZNE* ; Iben, S. ; Harbauer, A. B. ; Oeckl, P.DZNE* ; Freischmidt, A.

2025
Springer International Publishing AG Cham (ZG)

This record in other databases:    

Please use a persistent id in citations: doi:10.1007/s00018-025-05898-0

Abstract: Members of the fragile X protein (FXP) family (FMR1, FXR1 and FXR2) are differentially expressed in most types of cancer and major neurodegenerative diseases. While increased expression of FXR1 in cancer has been linked to senescence evasion and consequently tumor initiation and progression, decreased expression of FXPs in neurodegeneration may contribute to pathogenic protein aggregation and death of vulnerable neurons. However, due the causal role in fragile x syndrome, most data are available about loss of FMR1 in neurons while functions of FXR1 and especially FXR2 remain largely unexplored. To address this knowledge gap, and to directly compare functions of the FXPs, we used proteomics of CRISPR/Cas9 edited HAP1 cells carrying knockouts of the individual FXPs for identification of cellular mechanisms associated with these proteins. Further exploration of proteomic findings suggests roles of the FXPs in ribosome biogenesis, autophagy and mitochondrial health linked to organismal aging, and cellular senescence. Validation of FXP induced defects relevant for neurodegenerative diseases in neuroblastoma cell line SH-SY5Y upon FXP knockdown revealed high cell type specificity of individual FXP functions. Overall, we provide a comprehensive overview and comparison of cellular mechanisms related to the individual FXPs, as well as starting points for further studying this protein family in respective cell types of FXP associated diseases, and in aging in general.

Keyword(s): Humans (MeSH) ; Cellular Senescence: genetics (MeSH) ; Fragile X Mental Retardation Protein: genetics (MeSH) ; Fragile X Mental Retardation Protein: metabolism (MeSH) ; Aging: genetics (MeSH) ; Aging: metabolism (MeSH) ; RNA-Binding Proteins: metabolism (MeSH) ; RNA-Binding Proteins: genetics (MeSH) ; CRISPR-Cas Systems (MeSH) ; Autophagy (MeSH) ; Cell Line, Tumor (MeSH) ; Proteomics: methods (MeSH) ; Mitochondria: metabolism (MeSH) ; Fragile X Syndrome: metabolism (MeSH) ; Fragile X Syndrome: genetics (MeSH) ; Fragile X Syndrome: pathology (MeSH) ; Neurodegenerative Diseases: metabolism (MeSH) ; Neurodegenerative Diseases: genetics (MeSH) ; Neurodegenerative Diseases: pathology (MeSH) ; Alzheimer’s disease ; Amyotrophic lateral sclerosis ; Fragile x syndrome ; Parkinson’s disease ; Protein aggregation ; Fragile X Mental Retardation Protein ; RNA-Binding Proteins ; FMR1 protein, human ; FXR1 protein, human

---

Contributing Institute(s):

1. Mechanisms of Propagation (AG Danzer)
2. Translational Mass Spectrometry and Biomarker Research (AG Öckl)

Research Program(s):

1. 352 - Disease Mechanisms (POF4-352) (POF4-352)
2. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2025

---

Database coverage:
; ; ; BIOSIS Previews ; BIOSIS Reviews Reports And Meetings ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---